Categories: CommerceDevelopmentEnergyTechHardwareInvestmentManagementMedTechProductProductionTechnology
Based in Issaquah, Washington, Olympic is a commercial stage medical device company leveraging expertise in neuromodulation and energy based technology to discover, develop and commercialize novel therapies to treat ocular diseases with high unmet needs. The company’s first product iTEAR100, cleared by FDA in 2020 is an external neuromodulation device to increase natural tear production by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production. Our leadership team brings extensive experience in developing and commercializing treatments for ophthalmic and other disease categories.
Location: United States, Washington, Issaquah
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 07.06.2021 | Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries | ISSAQUAH, Wash. and SHANGHAI, June 7, 2021 /PRNewswire/ -- Arctic Vision, a clinical stage biotech company focusing on innovative ophthalmology therapies for pan-ocular diseases, and Olympic Ophthalmics, a U.S.-based medical technology comp... |
| 07.06.2021 | Arctic Vision : Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries | ISSAQUAH, Wash. and SHANGHAI, June 6, 2021 /PRNewswire/ -- Arctic Vision, a clinical stage biotech company focusing on innovative ophthalmology therapies for pan-ocular diseases, and Olympic Ophthalmics, a U.S.-based medical technology comp... |
| 06.06.2021 | Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries | |
Reviews 0
